Description

Dengue virus (DV) infections cause undisputedly the most important arthropod-borne viral disease in terms of worldwide prevalence, human suffering, and cost. Worldwide DV infection prevalence in 2010 was between 284

Dengue virus (DV) infections cause undisputedly the most important arthropod-borne viral disease in terms of worldwide prevalence, human suffering, and cost. Worldwide DV infection prevalence in 2010 was between 284 to 528 million cases. Approximately 84% of these cases come from Asia and the Americas, where the cost for emerging economies can be as high as 580 million dollars per year. Thus, the need for an efficient vaccine against DV is extreme.

Reuse Permissions
  • application/pdf

    Download count: 0

    Details

    Contributors
    Date Created
    • 2013-10-03
    Resource Type
  • Text
  • Collections this item is in
    Identifier
    • Digital object identifier: 10.1371/journal.ppat.1003551
    • Identifier Type
      International standard serial number
      Identifier Value
      1553-7366
    • Identifier Type
      International standard serial number
      Identifier Value
      1553-7374

    Citation and reuse

    Cite this item

    This is a suggested citation. Consult the appropriate style guide for specific citation guidelines.

    Angel, R. M., & Valle, J. R. (2013). Dengue Vaccines: Strongly Sought but Not a Reality Just Yet. PLoS Pathogens, 9(10). doi:10.1371/journal.ppat.1003551

    Machine-readable links